• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】15984

【品名】amino(imino)methanesulfonic acid

【CA登记号】

【 分 子 式 】CH4N2O3S

【 分 子 量 】124.12044

【元素组成】C 9.68% H 3.25% N 22.57% O 38.67% S 25.83%

与该中间体有关的原料药合成路线共 2 条

合成路线1

该中间体在本合成路线中的序号:(X)

1) The esterification of N-acetylneuraminic acid (I) with methanol/HCl gives the corresponding methyl ester (II), which is acetylated with acetic anhydride, pyridine and dimethylaminopyridine (DMAP) yielding the pentaacetate (III). The reaction of (III) with trimethylsilyl trifluoromethanesulfonate in ethyl acetate affords the 2,3-didehydro derivative (IV), which is treated with trimethylsilyl azide in butanol to give the 4-azido derivative (V). The selective deacetylation of (V) with sodium methoxide in methanol yields N-acetyl-4-azido-2,4-dideoxy-2,3-didehydroneuraminic acid methyl ester (VI), which is reduced with H2 over Lindlar catalyst (Pd-Pb) in water and treated with Dowex 8x2 resin to afford the N-acetyl-4-amino-2,4-dideoxy-2,3-didehydroneuraminic acid (VII). The reaction of (VII) with BrCN and sodium acetate in methanol gives the corresponding 4-cyanoamino derivative (VIII), which is converted into the final product by reaction with ammonium formate in aqueous NH4OH. 2) The amino derivative (VII) can be converted directly into the final product by reaction with amidinosulfonic acid (X), NaOH and K2CO3 in water. 3) The amino derivative (VII) can also be converted directly into the final product by reaction with pyrazole-1-carboxamidine (XI) and triethylamine in water.

1 Chandler, M.; Bamford, M.J.; Conroy, R.; et al.; Synthesis of the potent influenza neuraminidase inhibitor 4-guanidino Neu5Ac2en. X-Ray molecular structure of 5-acetamido-4-amino-2,6-anhydro-3,4,5-trideoxy-D-erythro-L-gluco-nononic acid. J Chem Soc - Perkins Trans I 1995, 9, 7, 1173-80.
2 von Itzstein, M.; Wu, W.-Y.; Jin, B.; The synthesis of 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid: A potent influenza virus sialidase inhibitor. Carbohydr Res 1994, 259, 2, 301-5.
3 Fromtling, R.; Castaner, J.; Zanamivir. Drugs Fut 1996, 21, 4, 375.
4 Weir, N.G.; Chandler, M.; Bamford, M.J. (Glaxo Wellcome plc); Synthesis of N-acetyl neuraminic acid derivs. WO 9407885 .
5 Patel, V. (Glaxo Wellcome plc); Synthesis of N-acetyl neuraminic acid derivs. WO 9407886 .
6 Chandler, M.; Weir, N. (Glaxo Wellcome plc); Preparation of N-acetyl neuraminic derivs. WO 9312105 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 15975 (2S,4S,5R,6R)-5-(acetamido)-2,4-dihydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]tetrahydro-2H-pyran-2-carboxylic acid 131-48-6 C11H19NO9 详情 详情
(II) 15976 methyl (2S,4S,5R,6R)-5-(acetamido)-2,4-dihydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]tetrahydro-2H-pyran-2-carboxylate 50998-13-5 C12H21NO9 详情 详情
(III) 15977 methyl (2R,4S,5S,6R)-5-(acetamido)-2,4-bis(acetoxy)-6-[(1S,2R)-1,2,3-tris(acetoxy)propyl]tetrahydro-2H-pyran-2-carboxylate C22H31NO14 详情 详情
(IV) 15978 methyl (3aS,4R,7aR)-2-methyl-4-[(1S,2R)-1,2,3-tris(acetoxy)propyl]-3a,7a-dihydro-4H-pyrano[3,4-d][1,3]oxazole-6-carboxylate C18H23NO10 详情 详情
(V) 15979 methyl (2R,3R,4S)-3-(acetamido)-4-azido-2-[(1S,2R)-1,2,3-tris(acetoxy)propyl]-3,4-dihydro-2H-pyran-6-carboxylate C18H24N4O10 详情 详情
(VI) 15980 methyl (2R,3R,4S)-3-(acetamido)-4-azido-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylate C12H18N4O7 详情 详情
(VII) 15981 (2R,3R,4S)-3-(acetamido)-4-amino-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid C11H18N2O7 详情 详情
(VIII) 15982 (2R,3R,4S)-3-(acetamido)-4-(cyanoamino)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid C12H17N3O7 详情 详情
(IX) 15983 1H-pyrazole-1-carboximidamide 4023-00-1 C4H6N4 详情 详情
(X) 15984 amino(imino)methanesulfonic acid CH4N2O3S 详情 详情

合成路线2

该中间体在本合成路线中的序号:(VII)

The monosulfonation of orcinol (I) with 2-chlorobenzenesulfonyl chloride (II) in ethyl ether/aqueous NaHCO3 gives the monosulfonate (III), which is condensed with 4-(methanesulfonyloxymethyl)piperidine-1-carboxylic acid tert-butyl ester (IV) by means of NaH in DMF to yield the aryl ether (V). The deprotection of (V) with 4N HCl in dioxane affords the piperidine (VI), which is finally treated with amidinosulfonic acid (VII) and TEA in DMF. The 4-(methanesulfonyloxymethyl)piperidine-1-carboxylic acid tert-butyl ester (IV) has been obtained as follows: The reaction of piperidine-4-carboxylic acid (VIII) with Boc2O and NaHCO3 in dioxane/water gives the protected piperidine (IX), which is reduced at the carboxyl group by means of BH3/THF yielding the carbinol (X). Finally, this compound is mesylated with MsCl and TEA in dichloromethane to afford the target intermediate.

1 Soll, R.M.; Spurlino, J.; Murphy, L.; Lu, T.; Salemme, F.R.; Bone, R.; Illig, C.R.; Tomczuk, B.E.; Structure-activity and crystallographic analysis of a new class of non-amide-based thrombin inhibitor. Bioorg Med Chem Lett 2000, 10, 1, 79.
2 Zetter, B.R.; Smith, R. (Children's Medical Center Corp.); Treatment of human prostate cancer with spermine. WO 9711691 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 27257 5-Methyl-1,3-benzenediol; Orcinol 505-15-4 C7H8O2 详情 详情
(II) 30817 2-chlorobenzenesulfonyl chloride 2905-23-9 C6H4Cl2O2S 详情 详情
(III) 30818 3-hydroxy-5-methylphenyl 2-chlorobenzenesulfonate C13H11ClO4S 详情 详情
(IV) 40396 tert-butyl 4-([[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]methyl)-1-piperidinecarboxylate C14H27NO3S 详情 详情
(V) 40397 tert-butyl 4-[(3-[[(2-chlorophenyl)sulfonyl]oxy]-5-methylphenoxy)methyl]-1-piperidinecarboxylate C24H30ClNO6S 详情 详情
(VI) 40398 3-methyl-5-(4-piperidinylmethoxy)phenyl 2-chlorobenzenesulfonate C19H22ClNO4S 详情 详情
(VII) 15984 amino(imino)methanesulfonic acid CH4N2O3S 详情 详情
(VIII) 17402 4-nipecotic acid;piperidine-4-carboxylic acid;p-nipecotic acid; Isonipecotic acid; Hexahydroisonicotinic acid; 4-Piperidinecarboxylic acid 498-94-2 C6H11NO2 详情 详情
(IX) 17404 1-(tert-butoxycarbonyl)-4-piperidinecarboxylic acid; 1-BOC-piperidine-4-carboxylic acid; N-Boc-isonipecotic acid 84358-13-4 C11H19NO4 详情 详情
(X) 40399 tert-butyl 4-(hydroxymethyl)-1-piperidinecarboxylate C11H21NO3 详情 详情
Extended Information